Noven announced that the Food and Drug Administration (FDA) has approved a new indication with a new dose of Minivelle (estradiol transdermal system) for the prevention of postmenopausal osteoporosis.
Celgene announced that the Food and Drug Administration (FDA) has approved Otezla (apremilast) for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
AbbVie announced that the Food and Drug Administration (FDA) has approved Humira (adalimumab) for reducing signs and symptoms, and achieving and maintaining clinical remission, in pediatric Crohn's disease for patients ≥6 years old when certain other treatments were inadequate.
The American Orthopaedic Foot & Ankle Society (AOFAS) has released a list of tests and procedures that are commonly ordered but not always necessary.
Merck announced results from the Phase 3 LOFT study with odanacatib in postmenopausal women with osteoporosis.
Mylan announced the launch of Ibandronate Sodium Injection, the generic version of Roche's Boniva Injection.
Exclusive access to live, onsite coverage of up-to-date evidence-based scientific findings in pain management.
Review this chart for quick information when you need it.